The U.S. Department of Justice said on Thursday it would immediately loosen restrictions on some marijuana products and move Read More
April 24, 2026
The United States Department of Justice is easing rules on certain marijuana items. The drug will be reclassified as less Read More
April 23, 2026
The Trump administration reclassified medical marijuana as a less dangerous drug on Thursday. FDA-approved and state-licensed medical marijuana was rescheduled Read More
April 23, 2026
President Donald Trump’s acting attorney general on Thursday signed an order reclassifying state-licensed medical marijuana as a less-dangerous drug, Read More
April 23, 2026
Rescheduling could reshape cannabis industry dynamics, impacting market perceptions, regulatory frameworks, and investment strategies. The post US reschedules medical marijuana Read More
April 23, 2026
The Department of Justice said it will immediately move FDA-approved marijuana from Schedule I to Schedule III under the Controlled Read More
April 23, 2026
The US Department of Justice has reclassified medical cannabis under Donald Trump’s direction Donald Trump’s administration has taken Read More
April 23, 2026
President Donald Trump’s administration has reclassified medical marijuana as a less dangerous drug. The order, signed Thursday, marks a Read More
April 23, 2026
Acting Attorney General Todd Blanche’s distinction between medical and recreational cannabis is hard to reconcile with the relevant scientific Read More
April 23, 2026
CHICAGO Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (Cresco Labs or the Company), today issued a statement on Read More